Non-viral delivery of RNA for therapeutic T cell engineering
Engineering the Delivery System for CRISPR-Based Genome Editing
Chimeric antigen receptor–engineered regulatory T lymphocytes
Engineered exosome-mediated messenger RNA and single-chain variable fragment delivery for human chimeric antigen receptor T-cell engineering - Cytotherapy
Engineering RNA export for measurement and manipulation of living
Biomaterials for chimeric antigen receptor T cell engineering
Oral non-viral gene delivery platforms for therapeutic
INSPIRED Symposium Part 4B: Chimeric Antigen Receptor T Cell Correlative Studies—Established Findings and Future Priorities - Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation and Cellular Therapy
Uptake mechanisms of non-viral gene delivery - ScienceDirect
Elena Sotillo on LinkedIn: A versatile CRISPR-Cas13d platform for
Frontiers The Past, Present, and Future of Non-Viral CAR T Cells
Lipid nanoparticles outperform electroporation in mRNA-based CAR T
